Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma

被引：210
|
作者：
Chen, Jiang [1 ]
Jin, Renan [1 ]
Zhao, Jie [1 ]
Liu, Jinghua [1 ]
Ying, Hanning [1 ]
Yan, Han [1 ]
Zhou, Senjun [1 ]
Liang, Yuelong [1 ]
Huang, Diyu [1 ]
Liang, Xiao [1 ]
Yu, Hong [1 ]
Lin, Hui [1 ]
Cai, Xiujun [1 ]
机构：
[1] Zhejiang Univ, Dept Gen Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China
来源：
CANCER LETTERS | 2015年 / 367卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Advanced hepatocellular carcinoma (HCC); Epithelial-mesenchymal transitions (EMT) and mesenchymal epithelial transitions (MET); Cancer stem cells (CSCs); Microenvironment; Acquired resistance; EPITHELIAL-MESENCHYMAL TRANSITION; HEDGEHOG SIGNALING PATHWAY; ALPHA-B-CRYSTALLIN; LIVER-CANCER CELLS; PHASE-III; PROMOTES METASTASIS; DEPENDENT MECHANISM; PLUS SORAFENIB; BREAST-CANCER; UP-REGULATION;
D O I：
10.1016/j.canlet.2015.06.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sorafenib, an orally-available kinase inhibitor, is the only standard clinical treatment against advanced hepatocellular carcinoma. However, development of resistance to sorafenib has raised concern in recent years due to the high-level heterogeneity of individual response to sorafenib treatment. The resistance mechanism underlying the impaired sensitivity to sorafenib is still elusive though some researchers have made great efforts. Here, we provide a systemic insight into the potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma depending on abundant previous studies and reports. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：1 / 11
页数：11
相关论文
共 50 条
  • [21] Identification of microRNAs involved in the resistance to sorafenib in hepatocellular carcinoma
    Kogure, Takayuki
    Inoue, Jun
    Kakazu, Eiji
    Ninomiya, Masashi
    Umetsu, Teruyuki
    Takai, Satoshi
    Nakamura, Takuya
    Kondo, Yasuteru
    Shimosegawa, Tooru
    HEPATOLOGY, 2016, 64 : 268A - 268A
  • [22] Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
    Bo Zhai
    Xue-Ying Sun
    World Journal of Hepatology, 2013, (07) : 345 - 352
  • [23] Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma
    Sun, Ting
    Liu, Hongchun
    Ming, Liang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 44 (02) : 716 - 727
  • [24] Autophagy Facilitates the Sorafenib Resistance of Hepatocellular Carcinoma Cells
    Liu, B.
    Cao, Y.
    Jiang, H.
    Mao, A.
    WEST INDIAN MEDICAL JOURNAL, 2013, 62 (08): : 698 - 700
  • [25] Effects of aspirin on hepatocellular carcinoma and its potential molecular mechanism
    Yuan, Zhilu
    Zhao, Jingfei
    Wang, Zhengtang
    Ren, Guoyan
    Zhang, Zhongbao
    Ma, Genshun
    JOURNAL OF BUON, 2020, 25 (02): : 981 - 986
  • [26] POTENTIAL BIOMARKERS OF SORAFENIB THERAPY IN ADVANCED HEPATOCELLULAR CARCINOMA
    Negri, Francesca V.
    Dal Bello, Barbara
    Campanini, Nicoletta
    Rossi, Sandro
    Porta, Camillo
    Tinelli, Carmine
    Poggi, Guido
    Missale, Gabriele
    Bisagni, Giancarlo
    Ardizzoni, Andrea
    Silini, Enrico M.
    ANNALS OF ONCOLOGY, 2011, 22 : v20 - v20
  • [27] Underlying mechanism of sorafenib resistance in hepatocellular carcinoma: a bioinformatics study based on validated resistance-related genes
    Song, Yu
    Gao, Peng
    Ding, Haiying
    Xu, Gaoqi
    Hu, Yan
    Tong, Yinghui
    Xin, Wenxiu
    Zhang, Liwen
    Wu, Miaolian
    Fang, Luo
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (04) : 1895 - 1904
  • [28] Exploring the potential mechanisms of sorafenib resistance in hepatocellular carcinoma cell lines based on RNA sequencing
    Sun, Minghui
    Zhang, Zhi
    Chen, Chunyan
    Zhong, Juan
    Long, Zhongrong
    Shen, Ling
    Huang, Hai
    Lu, Jianxun
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [29] Sorafenib in Hepatocellular Carcinoma
    Bajetta, Emilio
    Procopio, Giuseppe
    Colombo, Andrea
    Guadalupi, Valentina
    Verzoni, Elena
    Pietrantonio, Filippo
    Pusceddu, Sara
    Manzoni, Mariangela
    Gevorgyan, Arpine
    Buzzoni, Roberto
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 277 - 287
  • [30] Sorafenib in hepatocellular carcinoma
    Josephs, Debra H.
    Ross, Paul J.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (08) : 451 - 456
12345